LOS ANGELES, Feb. 10, 2026 (GLOBE NEWSWIRE) -- XiXi Yang Home officially launches with the debut of the Golden Hour Collection, a sculptural lighting collaboration with MOD LIGHTING, one of the ...

Think about how it feels when you’re prescribed most medications. Your doctor or pharmacist gives you specific instructions to follow—“Take it in the morning with food,” or “Avoid eating grapefruit ...

Real-world data suggests weight loss durability post-GLP-1 drug discontinuation Study suggests weight regain may be less common than clinical trial extensions indicate Behavioral changes may aid ...

Too good to be true? While blockbuster GLP-1 drugs continue to reach new heights in popularity, they’re not without potential downsides, like bizarre side effects such as “Ozempic feet.” And while ...

A Wegovy pill is now available in pharmacies nationwide. The weight loss medication is an alternative to GLP-1 injections. Below, a weight loss expert shares what you need to know. Wegovy—a medication ...

Ending treatment with a GLP-1 obesity drug often led to steady weight regain — usually faster than after quitting diet- and exercise-based programs, a new research review found. Health improvements ...

Drugs like Ozempic and Wegovy have had a meteoric rise in recent years, with benefits like weight loss and help with other health issues. But according to a recent study, those benefits fade within ...

Many people who stop using weight loss drugs will return to their previous weight within two years, a new review of existing research has found. This rate of weight regain is significantly faster than ...

Nothing lasts forever, including the pounds shed in a GLP-1 program. A major study published this week finds that people who stop taking weight-loss injections regain all the weight they originally ...

People who stop taking weight-loss medications for the treatment of obesity gain the weight back within an average of 1.7 years, and this rebound is accompanied by a worsening of cardiometabolic risk ...

The sustainability of weight-loss drugs is under scrutiny as new research shows that people who stop taking glucagon-like peptide-1 (GLP-1) agonists regain the pounds at a steady rate, returning to ...